Tau protein is an important protein in the human body that helps maintain the function and structure of neurons. It plays a role in microtubule assembly, stabilization, and transport. Microtubules are essential for cell division, transport of organelles and materials, and neuronal signaling. Specifically, tau proteins bind to tubulin molecules and organize the microtubules into bundles which stabilize thecytoskeleton. Tau proteins come in two forms—3R and 4R. 3R tau is more predominant in humans, while 4R tau is the more prevalent form in other species and in humans with certain neurological conditions. Mutations in the tau gene can cause a variety of conditions, including dementia, Alzheimer’s disease, frontotemporal lobar degeneration, and progressive supranuclear palsy. In healthy people, tau helps regulate the structure and function of neurons, which are responsible for storing and transmitting information throughout the body. In Alzheimer’s disease, however, tau proteins begin to accumulate in the axon of neurons, forming neurofibrillary tangles. These tangles interfere with the normal function of neurons, resulting in memory and cognitive impairment. Another implication of tau proteins is the process of aggregation. When tau proteins become chemically modified, they are prone to clustering and forming fibers called paired helical filaments. These fibers, in turn, form insoluble aggregations called neurofibrillary tangles, which are a hallmark of Alzheimer’s disease and other neurological disorders. Tau proteins and its related diseases are the subject of scientific investigation, as research continues to explore its functions and potential therapies. Tau proteins have been used to target therapies for Alzheimer’s disease, stroke, and other neurological diseases. Understanding the nuances of its role in neuronal health and disease could lead to improved treatment modalities for debilitating neurological conditions.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States